Publications by authors named "Jeivicaa Thevan"
Dermatology
December 2024
Article Synopsis
- - Dupilumab shows promise as a treatment for bullous pemphigoid (BP), allowing for the rapid identification of patients who respond to the therapy, which could reduce the need for additional immunosuppressive treatments.
- - In a study of 12 BP patients, 67% had a complete response and a significant reduction in itch (pruritus) was noted as early as day 1, with a correlation to clinical improvement by day 14.
- - The findings suggest that monitoring itch levels can be a useful early indicator of treatment response, potentially altering BP treatment protocols in the future to minimize reliance on more harmful therapies.
